Search articles by title, topic or section.
Khabre desk
Recent reporting, analysis and explainers from the medicines desk.
health
NHS England will make trastuzumab deruxtecan, sold as Enhertu, available to around 1,000 women with HER2-low advanced or metastatic breast cancer after their disease progresses following treatment.
health
EMA’s Committee for Medicinal Products for Human Use issued positive opinions for 12 medicines at its 14–17 September 2026 meeting, including a rabies vaccine, two biosimilars and two generics. The recommendations remain subject to European Commission decisions.